Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid

The prevention of fractures is the ultimate goal of osteoporosis treatments. To achieve this objective, developing a method to predict fracture risk in the early stage of osteoporosis treatment would be clinically useful. This study aimed to develop a mathematical model quantifying the long‐term fra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasai, Hidefumi, Mori, Yoko, Ose, Atsushi, Shiraki, Masataka, Tanigawara, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048549/
https://www.ncbi.nlm.nih.gov/pubmed/33135182
http://dx.doi.org/10.1002/jcph.1774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048549/
https://www.ncbi.nlm.nih.gov/pubmed/33135182
http://dx.doi.org/10.1002/jcph.1774

Ejemplares similares